Q4047 – Cast supplies, short leg splint, pediatric (0-10 years), plaster
HCPCS Level II code · Q codes: Temporary Codes
HCPCS codeQ4047
- Long description
- Cast supplies, short leg splint, pediatric (0-10 years), plaster
- Short description
- Cast sup sht leg splnt ped p
- Pricing indicator
55Splints and casts- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
D1AMedical/surgical supplies- Added
- July 1, 2001
- Last change
- October 1, 2014 – No change
Frequently asked questions
What is HCPCS code Q4047?
Q4047 is a HCPCS Level II code for cast supplies, short leg splint, pediatric (0-10 years), plaster.
Does Medicare cover Q4047?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby Q codes
- Q4039 – Cast supplies, short leg cast, pediatric (0-10 years), plaster
- Q4040 – Cast supplies, short leg cast, pediatric (0-10 years), fiberglass
- Q4041 – Cast supplies, long leg splint, adult (11 years +), plaster
- Q4042 – Cast supplies, long leg splint, adult (11 years +), fiberglass
- Q4043 – Cast supplies, long leg splint, pediatric (0-10 years), plaster
- Q4044 – Cast supplies, long leg splint, pediatric (0-10 years), fiberglass
- Q4045 – Cast supplies, short leg splint, adult (11 years +), plaster
- Q4046 – Cast supplies, short leg splint, adult (11 years +), fiberglass
- Q4048 – Cast supplies, short leg splint, pediatric (0-10 years), fiberglass
- Q4049 – Finger splint, static
- Q4050 – Cast supplies, for unlisted types and materials of casts
- Q4051 – Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)
- Q4074 – Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms
- Q4081 – Injection, epoetin alfa, 100 units (for esrd on dialysis)
- Q4082 – Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)
- Q4100 – Skin substitute, not otherwise specified
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.